Search results
Results from the WOW.Com Content Network
Prior to the vaping crisis, publicly traded cannabis companies like Canopy Growth (NYSE:CGC) were already under fire. Due to a series of disappointing earnings performances from the industry as a ...
By Gary BourgeaultI think the gushing over Canopy Growth (CGC) may be gradually coming to an end, as the company attempts to position itself as an international and medical cannabis player, when ...
From a broad standpoint, the case for Canopy Growth (NYSE:CGC) stock has been relatively simple. Specifically, the argument has been that CGC stock offers the simplest way to play the cannabis ...
It was clear and obvious at the time of the firing of Canopy Growth (CGC) co-CEO Bruce Linton, that Constellation Brands wanted the company to start to move toward lowering costs and widening ...
Like many cannabis stocks, Canopy Growth (NYSE:CGC) fell in Monday trading due to an FDA meeting on CBD. Marijuana stocks fell as speakers at this inquiry offered conflicting views of the ...
Canopy Growth (NYSE:CGC) stock fell on Friday following comments by the largest investor in CGC stock, Constellation Brands (NYSE:STZ). Though Canopy stock recovered on Monday, this was another in ...
Canopy Growth (NYSE:CGC) is a popular stock for cannabis investors due to the company's high valuation. But the company's growth story is much less compelling than it was a year ago. CGC stock is ...
Since early 2019, Canopy Growth (NASDAQ:CGC) has suffered a grueling bear move. During this period, CGC stock has gone from $50 to just under $24. The market capitalization is now at $8.9 billion ...